Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

What is driving fresh covid surge? AIIMS director Randeep Guleria answers

What is driving fresh covid surge? Former AIIMS director Randeep Guleria answers

What is driving fresh covid surge? former AIIMS director Randeep Guleria answers

India recorded 1,134 new coronavirus cases, the highest in 138 days, while the active cases increased to 7,026, according to the Union Health Ministry data updated on Wednesday.

As India witnessed the highest number of Covid cases in over four months, former AIIMS director Dr Randeep Guleria on Wednesday said the new XBB.1.16 variant could be driving the recent rise but emphasised there was no need for panic as long it does not cause severe illness and deaths.
New variants will keep coming as the virus keeps on mutating over the time and the XBB 1.16 is sort of a "new kid on the block", Guleria told PTI in an interview.
"... As long as they don't lead to severe illness, hospitalisation and deaths, it is alright because it helps in giving some degree of immunity to the population if they have mild illness," the renowned pulmonologist, who was part of the national Covid task force, said.
India recorded 1,134 new coronavirus cases, the highest in 138 days, while the active cases increased to 7,026, according to the Union Health Ministry data updated on Wednesday.
Also Watch: <a href="https://www.editorji.com/india-news/local/pm-modi-stresses-on-covid-appropriate-behaviour-in-key-health-meet-in-delhi-1679502212386">PM Modi stresses on Covid-appropriate behaviour in key health meet in Delhi</a>

Amid a war of words between the BJP and the Aam Aadmi Party over the Oxygen Audit report by a Supreme Court mandated Committee, AIIMS chief Dr Randeep Guleria, who led the audit has now said, it would not be correct to say that Delhi "exaggerated" its oxygen needs by four times during the second wave of Covid.
In an interview to NDTV, AIIMS chief Dr Randeep Guleria said, the Delhi oxygen audit is an interim report and the final report is yet to come. Asked whether the report was exaggerated four times, Dr Guleria replied, "I don't think we could say that". He added, that the matter is in the Supreme Court and we need to wait and see what the top court says about it. Guleria said under-counting of active cases and other factors also need to be considered.
On Friday, the report circulated by media outlets said, that the Delhi government "exaggerated" the capital's oxygen needs by four times at the peak of the second wave and the supply of excess oxygen to Delhi "affected other states".

AIIMS chief who led audit: Can't say Delhi govt exaggerated oxygen demand by 4X

Dr Randeep&nbsp;Guleria,&nbsp;AIIMS chief who led audit of oxygen usage, says&nbsp;"Can't say Delhi govt exaggerated oxygen demand by 4X"

AIIMS&nbsp;chief says can't say that Delhi 'exaggerated' O2 demand by 4X
Dr Randeep&nbsp;Guleria&nbsp;heads sub group that led the O2 audit for Covid
Report set off a clash between the Centre and AAP&nbsp;govt in Delhi
Guleria: Delhi oxygen audit is an interim report, full report yet to come
Report said Delhi demanded 4X more oxygen putting other states at risk
&nbsp;

The report by an SC-mandated committee said that Delhi "exaggerated" the capital's oxygen needs by four times at the peak of the second wave and the supply of excess oxygen to Delhi "affected other states".

Amid a war of words between the BJP and the Aam Aadmi Party over the Oxygen Audit report by a Supreme Court mandated Committee, AIIMS chief Dr Randeep Guleria, who led the audit has now said, it would not be correct to say that Delhi "exaggerated" its oxygen needs by four times during the second wave of Covid.
In an interview to NDTV, AIIMS chief Dr Randeep Guleria said, the Delhi oxygen audit is an interim report and the final report is yet to come. Asked whether the report was exaggerated four times, Dr Guleria replied, "I don't think we could say that". He added, that the matter is in the Supreme Court and we need to wait and see what the top court says about it. Guleria said under-counting of active cases and other factors also need to be considered.
On Friday, the report circulated by media outlets said, that the Delhi government "exaggerated" the capital's oxygen needs by four times at the peak of the second wave and the supply of excess oxygen to Delhi "affected other states".

AIIMS director Dr Randeep Guleria has said that Hyderabad based Bharat Biotech&rsquo;s anti-Covid-19 shot, Covaxin, is likely to be approved for children by September.
Dr Guleria told India Today that the trial data would be made available by September and the vaccine itself is likely to be approved in the same month.
He further added that the Pfizer-BioNTech shot, if approved in India, could be another alternative for children to be vaccinated with.
As several experts have projected that a potential third wave will be particularly hard-hitting on children, Covaxin&rsquo;s trial on children, aged between 2 and 17, is being conducted at AIIMS Delhi and Patna

AIIMS chief Dr Guleria: Covaxin likely to be approved for children by September

<ul>
<li>AIIMS chief:&nbsp;Covaxin likely to be approved for children by September</li>
<li>Dr Guleria: Covaxin&nbsp;trial data would be available by September&nbsp;</li>
<li>Pfizer-BioNTech shot another alternative for children,&nbsp;Dr Guleria&nbsp;said</li>
<li>Experts believe a potential third wave will hit children hard</li>
<li>Covaxin&rsquo;s trial on children being conducted at AIIMS Delhi &amp;&nbsp;Patna</li>
</ul>

AIIMS director Dr Randeep Guleria has said that Hyderabad based Bharat Biotech&rsquo;s anti-Covid-19 shot, Covaxin&nbsp;is likely to be approved for children by September.
Dr Guleria told India Today that the trial data would be made available by September and the vaccine itself is likely to be approved in the same month.
He further added that the Pfizer-BioNTech shot, if approved in India, could be another alternative for children to be vaccinated with.
As several experts have projected that a potential third wave will be particularly hard-hitting on children, Covaxin&rsquo;s trial on children, aged between 2 and 17, is being conducted at AIIMS Delhi and Patna

AIIMS Director Dr Randeep Guleria said on Monday that there is no data anywhere in the world to corroborate the fact that the third wave of Covid-19 infections could affect children more than others.He added that according to the second wave data, out of all the children admitted to hospitals with Covid-19, 60-70% had co-morbidities or low immunity, some were on chemo therapy. Guleria said, most healthy children who were infected recovered without the need for hospitalisation.NITI Aayog member Dr VK Paul said, that it would be difficult for the virus to reach children if more and more adults get vaccinated.

60-70% children hospitalised for Covid had co-morbidities: Dr Randeep Guleria

60-70% children hospitalised for Covid&nbsp;during the second wave had co-morbidities, says AIIMS&nbsp;Director&nbsp;Dr Randeep Guleria

AIIMS&nbsp;chief: no data to show that 3rd Covid&nbsp;wave will affect kids
Dr Randeep&nbsp;Guleria: kids hospitalised during 2nd wave had co-morbidities
60-70% kids&nbsp;had co-morbidities,&nbsp;low immunity, were on chemo: Guleria
Most infected children recovered without need for hospitalisation: Guleria
Dr VK Paul: difficult for virus to reach kids if more adults are vaccinated
&nbsp;

AIIMS Director Dr Randeep Guleria said on Monday that there is no data anywhere in the world to corroborate the fact that the third wave of Covid-19 infections could affect children more than others. He added that according to the second wave data, out of all the children admitted to hospitals with Covid-19, 60-70% had co-morbidities or low immunity, some were on chemo therapy. Guleria said, most healthy children who were infected recovered without the need for hospitalisation. NITI Aayog member Dr VK Paul said, that it would be difficult for the virus to reach children if more and more adults get vaccinated.

Study: spike in pollution can cause a surge of 8-9% Covid cases 

In an interview to India Today, AIIMS Director Dr&nbsp;Randeep Guleria said that even a slight increase in pollution will increase the coronavirus cases in the country. A Lancet study has shown that even a little bit of increase in PM 2.5 levels lead to a surge of at least 8-9% increase in Covid cases. Data also suggests that India has two peak seasons for influenza-like-illnesses, one being monsoon and the other being winter, since&nbsp;Covid-19 is a respiratory viral infection behaves almost like influenza. Dr Guleria cautioned against crowding and carelessness and said that wearing a mask, practicing physical distance and hand hygiene could reduce the cases by at least 30-40%.

Slightest increase in pollution&nbsp;can cause spike in Covid cases
AIIMS&nbsp;Director: increase in PM 2.5 levels will cause surge
Winter &amp; monsoon peak seasons for influenza like illnesses&nbsp;
Dr Randeep&nbsp;Guleria&nbsp;cautions against crowding, carelessness&nbsp;
Wearing masks, social distancing will reduce cases by 30-40%
&nbsp;

In an interview to India Today, AIIMS Director Dr&nbsp;Randeep Guleria said that even a slight increase in pollution will increase the coronavirus cases in the country. A Lancet study has shown that even a little bit of increase in PM 2.5 levels lead to a surge of at least 8-9% increase in Covid cases. Data also suggests that India has two peak seasons for influenza-like-illnesses, one being monsoon and the other being winter, since&nbsp;Covid-19 is a respiratory viral infection behaves almost like influenza. Dr Guleria cautioned against crowding and carelessness and said that wearing a mask, practicing physical distance and hand hygiene could reduce the cases by at least 30-40%.

randeep guleria

Categories